8-K - Cadrenal Therapeutics, Inc. Common Stock | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Other Events. On February 24, 2026, Cadrenal Therapeutics, Inc. (the “Company”) issued a press release announcing results from a Phase 2 trial evaluating CAD

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits The following exhibits are furnished with this Current Report on Form 8-K: Exhibit Number Exhibit Description 99

Exhibits Only

Source Document

Exhibits (2)

8-K

CURRENT REPORT

99.1

PRESS RELEASE, ISSUED BY CADRENAL THERAPEUTICS, INC. ON FEBRUARY 24, 2026